Mycobacterium Cell Wall Fraction Immunostimulant.
Equimune® is a USDA-approved immunotherapeutic for the treatment of Equine Respiratory Disease Complex (ERDC) of vial origin. Studies have shown that a single dose of Equimune generates a non-specific amplification of the immune response to antigens. This product is safe to use in pregnant mares.
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.